Matches in Wikidata for { <http://www.wikidata.org/entity/Q88169746> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q88169746 description "article scientifique publié en 2018" @default.
- Q88169746 description "artículu científicu espublizáu n'abril de 2018" @default.
- Q88169746 description "im April 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q88169746 description "scientific article published on 23 April 2018" @default.
- Q88169746 description "наукова стаття, опублікована у квітні 2018" @default.
- Q88169746 name "Safety and efficacy of apixaban versus warfarin in patients with end-stage renal disease: Meta-analysis" @default.
- Q88169746 type Item @default.
- Q88169746 label "Safety and efficacy of apixaban versus warfarin in patients with end-stage renal disease: Meta-analysis" @default.
- Q88169746 prefLabel "Safety and efficacy of apixaban versus warfarin in patients with end-stage renal disease: Meta-analysis" @default.
- Q88169746 P1433 Q88169746-5A43C73D-B727-4519-BD46-C5CF0DD1119D @default.
- Q88169746 P1476 Q88169746-9B042765-7810-4E94-8358-CDD1679B5350 @default.
- Q88169746 P2093 Q88169746-0339D350-5067-4529-A8E6-7ECA40D83C60 @default.
- Q88169746 P2093 Q88169746-BD296466-C716-4B8A-BADF-AF38E5001794 @default.
- Q88169746 P304 Q88169746-69ADD288-5E42-4ED8-BCE3-BA17D52EADAB @default.
- Q88169746 P31 Q88169746-6420F2B8-D3F5-418B-91B2-A3C82ABE9E13 @default.
- Q88169746 P31 Q88169746-fd871dbb-f858-4172-ba65-fbd97332c026 @default.
- Q88169746 P356 Q88169746-2FE78B7B-37E3-4DE6-88CF-DF8A403D5D7E @default.
- Q88169746 P433 Q88169746-434296AE-DA13-4247-AE1F-E1C35B9C1FA6 @default.
- Q88169746 P478 Q88169746-BCC630FF-2435-4F4A-9969-71D346C3016B @default.
- Q88169746 P50 Q88169746-100118FD-5B3F-47D9-81F0-80829705191E @default.
- Q88169746 P50 Q88169746-4055199E-CF70-48D0-AF65-DE5FAACEB57F @default.
- Q88169746 P50 Q88169746-82E0CF14-A40F-47C2-952B-81DA507ED830 @default.
- Q88169746 P50 Q88169746-B781F76E-14EB-4200-80FA-25B65854A876 @default.
- Q88169746 P577 Q88169746-F498A27F-8E73-4C2B-A195-EBBFFE75F30D @default.
- Q88169746 P698 Q88169746-1A3B763E-7AE5-4A12-9AE4-959E1FA7CEC5 @default.
- Q88169746 P921 Q88169746-5B2F05BD-BB0A-4A7A-9EF5-9F997EFA11F3 @default.
- Q88169746 P921 Q88169746-A780B243-6A2D-4CD1-BA04-0F9B9BF0A045 @default.
- Q88169746 P921 Q88169746-EAF0FB84-2BF8-42E7-AD78-A8AF259B423B @default.
- Q88169746 P356 PACE.13331 @default.
- Q88169746 P698 29577340 @default.
- Q88169746 P1433 Q2740882 @default.
- Q88169746 P1476 "Safety and efficacy of apixaban versus warfarin in patients with end-stage renal disease: Meta-analysis" @default.
- Q88169746 P2093 "Pavida Pachariyanon" @default.
- Q88169746 P2093 "Wisit Cheungpasitporn" @default.
- Q88169746 P304 "627-634" @default.
- Q88169746 P31 Q13442814 @default.
- Q88169746 P31 Q815382 @default.
- Q88169746 P356 "10.1111/PACE.13331" @default.
- Q88169746 P433 "6" @default.
- Q88169746 P478 "41" @default.
- Q88169746 P50 Q59682802 @default.
- Q88169746 P50 Q87201483 @default.
- Q88169746 P50 Q88169744 @default.
- Q88169746 P50 Q91791402 @default.
- Q88169746 P577 "2018-04-23T00:00:00Z" @default.
- Q88169746 P698 "29577340" @default.
- Q88169746 P921 Q1054718 @default.
- Q88169746 P921 Q407431 @default.
- Q88169746 P921 Q414462 @default.